Rho(D) Immune Globulin Supply

The contract entails the supply of pharmaceutical-grade Rho(D) Immune Globulin to be delivered to the USS TULSA LCS-16 at FPO AP 96691, ensuring full compliance with both FDA regulations and U.S. military standards for pharmaceutical products. The product must meet stringent quality and safety specifications required for deployment in a military maritime environment, with all manufacturing, labeling, and packaging adhering to established federal guidelines for immune globulin therapies. The shipment is expected to support maternal healthcare protocols aboard the vessel, particularly for Rh-negative pregnant personnel, in accordance with Department of Defense medical readiness requirements. This subcontract, identified under NAICS code 325412, was posted on August 2, 2026, with a response deadline of August 10, 2026, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. The place of performance is specified as FPO with ZIP code 96691, indicating delivery to a U.S. naval vessel operating in a forward-deployed or overseas location. While no point of contact or set-aside details are provided, the solicitation is accessible via the DIBBS system, and all bidders are expected to demonstrate proven capability in producing and distributing FDA-approved biological therapeutics under controlled conditions suitable for military logistics and storage environments.